Sanofi Consumer Sales Slow As Pandemic-Driven Surge Ends, But OTC Xyzal Line Still Shines

 
• By Eileen Francis
  
Xyzal , Sanofi Q
The Xyzal OTC allergy line was a bright spot in Sanofi's second-quarter consumer health results.
HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

SpotifyApple PodcastsWebsite

More from Business

More from Wellness